נפח מכירות החברה uniQure NV (QURE)

Sales revenue for uniQure N.V. (QURE) on the GURU.Markets base chart, which currently stands at 0.02, is supported by strong R&D potential and a team of geneticists. Growth is based on management's experience in bringing hemophilia treatments to market and expansion into neurobiology. Operational stability is guaranteed by established redundant logistics chains between US and European production sites.
פילוחים אנליטיים של חברת uniQure N.V.

Sales for uniQure N.V. (QURE) reflect the scale of gene technology commercialization through the total volume of products sold. This indicator captures the direct return from operating activities, measuring the cash inflow from market sales. By analyzing the company's commercial realization volumes, investors assess margin stability and expansion rates. Growth in this metric confirms the effectiveness of overcoming stringent FDA regulatory controls. Patent protection for AAV vectors guarantees the sustainability of these revenues.